New HLA TRACE™ Assays for Loss of HLA Heterozygosity Monitoring

/
New HLA TRACE™ Assays for Loss of HLA Heterozygosity Monitoring



JETA Molecular is proud to introduce new assays designed for monitoring of the genomic loss of the mismatched HLA haplotype (HLA LOH) following haploidentical HSCT. This event occurs in an average of 33% of post-HSCT patients and is sufficient to allow relapse of leukemia. The HLA TRACE™ assays represent a sensitive solution for the detection of LOH and may form the basis for optimising patient-tailored therapy.

Read More

Congresses in 2019

/
Congresses in 2019

JETA Molecular presented both its well-established products as well as novel strategies in DNA chimerism monitoring during the 33th EFI congress in Lisbon, May 8-11, and during the 2019 American Transplant Congress in Boston, June 1-5. You will also be able to meet our representatives at the SFHI meeting in Nancy, September 19-20, and at the ASHI 45th Annual Meeting in Pittsburgh, September 23-27. Feel free to come by!

Read More

Inno-train Diagnostik and JETA Molecular Ink Distribution and Co-Development Agreement

/
Inno-train Diagnostik and JETA Molecular Ink Distribution and Co-Development Agreement

Kronberg, Germany and Utrecht, Netherlands, 29 November 2018

inno-train Diagnostik and JETA Molecular announced today that they had entered into a sales  and co-development relationship. Under terms of their agreement, inno-train will distribute JETA’s QTRACE® Analysis System in the United States and Europe, with the exception of France. The company’s R&D teams will collaborate to co-develop new diagnostic applications, leveraging  each other’s product portfolios and domain expertise.

Read More

BioNoBis and JETA Molecular Awarded EFS Tender for Chimerism Monitoring

/
BioNoBis and JETA Molecular Awarded EFS Tender for Chimerism Monitoring

BioNoBis (Guyancourt, France) and JETA Molecular (Utrecht, The Netherlands) today announced that JETA’s new QTRACE® Analysis System for cell-free DNA and chimerism analysis by quantitative PCR (qPCR) has been selected as the chimerism monitoring solution of choice by the Établissement Français du Sang (EFS – the French National Blood Service). BioNoBis won a four-year, competitive tender to supply JETA’s reagents and software.

Read More